BIOCHEMICAL-CHARACTERIZATION OF SR48692, A SELECTIVE NONPEPTIDE ANTAGONIST OF THE NEUROTENSIN RECEPTOR

被引：0
|
作者：
OURYDONAT, F [1 ]
HEAULME, M [1 ]
THURNEYSSEN, O [1 ]
GONALONS, N [1 ]
GULLY, D [1 ]
LEFUR, G [1 ]
SOUBRIE, P [1 ]
机构：
[1] SANOFI RECH,F-34082 MONTPELLIER,FRANCE
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1994年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：U122 / U122
页数：1
相关论文
共 50 条
  • [31] SR 48692, a specific neurotensin receptor antagonist, has no effect on oesophageal motility in humans
    Zerbib, F
    Piche, T
    Charles, F
    Galmiche, JP
    Des Varannes, SB
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (08) : 931 - 939
  • [32] The synthesis of neurotensin antagonist SR 48692 for prostate cancer research
    Baxendale, I. R.
    Cheung, S.
    Kitching, M. O.
    Ley, S. V.
    Shearman, J. W.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (14) : 4378 - 4387
  • [33] SR48692 pretreatment blocks the protective and antiacid secretory effects of icv neurotensin in rats.
    Schmidt, GL
    Karinch, AM
    Kauffman, GL
    GASTROENTEROLOGY, 1998, 114 (04) : A1179 - A1179
  • [34] Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: Influence on the antinociceptive effect of morphine
    Smith, DJ
    Hawranko, AA
    Monroe, PJ
    Gully, D
    Urban, MO
    Craig, CR
    Smith, JP
    Smith, DL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (02): : 899 - 908
  • [35] Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems
    Azzi, M
    Betancur, C
    Sillaber, I
    Spanagel, R
    Rostène, W
    Bérod, A
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 (03) : 1158 - 1167
  • [36] SR48692 inhibits EGF receptor transactivation and proliferation of lung cancer cells.
    Moody, Terry W.
    Jensen, Robert T.
    CANCER RESEARCH, 2013, 73 (08)
  • [37] EFFECT OF THE NONPEPTIDE NEUROTENSIN ANTAGONIST, SR-48692, AND 2 ENANTIOMERIC ANALOGS, SR-48527 AND SR-49711, ON NEUROTENSIN BINDING AND CONTRACTILE RESPONSES IN GUINEA-PIG ILEUM AND COLON
    LABBEJULLIE, C
    DESCHAINTRES, S
    GULLY, D
    LEFUR, G
    KITABGI, P
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (01): : 267 - 276
  • [38] CHARACTERIZATION OF THE EFFECT OF SR48692 ON INOSITOL MONOPHOSPHATE, CYCLIC-GMP AND CYCLIC-AMP RESPONSES LINKED TO NEUROTENSIN RECEPTOR ACTIVATION IN NEURONAL AND NONNEURONAL CELLS
    OURYDONAT, F
    THURNEYSSEN, O
    GONALONS, N
    FORGEZ, P
    GULLY, D
    LEFUR, G
    SOUBRIE, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (02) : 1899 - 1905
  • [39] A neurotensin antagonist, SR 48692, inhibits colonic responses to immobilization stress in rats
    Castagliuolo, I
    Leeman, SE
    BartolakSuki, E
    Nikulasson, S
    Qiu, BS
    Carraway, RE
    Pothoulakis, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (22) : 12611 - 12615
  • [40] The neurotensin (NT) antagonist, SR48692, enhances activation of rat median raphe (MR) serotonergic (5-HT) neurons by sound stress.
    Corley, KC
    Phan, TH
    BoadleBiber, MC
    FASEB JOURNAL, 1996, 10 (03): : 758 - 758
12345